High materiality8/10
Insmed price target raised to $218 from $212 at Morgan Stanley
Why it may matterVerify against the original reporting
Upside implied by the higher target relative to current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises INSM target to $218 from $212; current price $129.56.
- Target raised to $218; price $129.56.
Key facts
- 01
Target: $218
- 02
Posted price: $129.56
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.